New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many By . Deidre McPhillips. Updated May 21, 2025, 12:39 PM ET. PUBLISHED May 21, 2025, 7:00 AM ET.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs FRIDAY, May 23, 2025 (HealthDay News) — A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in ...

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many By . Deidre McPhillips. Updated May 21, 2025, 12:39 PM ET. PUBLISHED May 21, 2025, 7:00 AM ET.

FDA crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many By CNN Newsource Published May 21, 2025 6:00 am ...

(CNN) — The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many ...